Unplanned Interruption of Radiotherapy in Head and Neck Cancers: report from a Regional Cancer Centre

Journal Title: Journal of Medical Science And clinical Research - Year 2017, Vol 5, Issue 4

Abstract

Background and Objectives: Any unplanned interruption in head and neck cancers can affect loco regional control rates. Treatment induced toxicities and radiotherapy equipment breakdown or maintenance are the commonest reasons for treatment interruption. We evaluated occurrence and causes of unplanned interruption of radiotherapy in patients of head and neck cancers receiving radical radiotherapy protocol. Material and Methods: We conducted a retrospective study of 60 patients enrolled for radical Radiotherapy in our Regional Cancer Centre and recorded all relevant details like; patient characteristics, treatment received as well as details of treatment interruptions. Observations: Most of the patients were in the age group 55-64 years with males comprising 63.3% of cases. Oral cavity was the commonest subsite involved (33.3%) followed by larynx (23.3%). 60% patients started their radiotherapy within 4 weeks of first visit to our OPD and in only 10% of cases waiting period contributed to delay of more than 4 weeks. The average radiotherapy dose received by patients was 65.4 Gy, and the average fraction number was 32.5. 38 patients (63.3%) received single agent cisplatin based concurrent chemotherapy. The average overall treatment time (OTT), including interruptions, was 50.1 days. Treatment interruption was seen in 46.6% cases, out of which treatment induced toxicity contributed to 71.4% and radiotherapy machine related issues lead to interruption in 28.5% patients. Mucositis was the commonest toxicity observed, in half the patients with interruptions. The treatment breaks were mainly compensated by increasing treatment time for all remaining fractions, as per the departmental protocol and/or by treating them on Saturday of last week also. Conclusion: All efforts should be made to prevent and minimize the treatment interruptions in patients receiving radiotherapy of head and neck cancers in view of clonogenic repopulation affecting the control rates. At the same time, all interruptions should be properly compensated by a standard departmental protocol.

Authors and Affiliations

Najmi Arshad Manzoor

Keywords

Related Articles

Review of Graft Choices for Anterior Cruciate Ligament

The question of which graft to use for anterior cruciate ligament (ACL) reconstruction continues to be debated at meetings around the world. The overall choice of grafts consists of autografts, allografts, and synthetic...

The Use of Buccal Fat Pad Reconstruction in Oral Submucous Fibrosis

An oral fibrosing disease was first described in the year 1952 by Schwartz which was later termed as “Oral Submucucous Fibrosis” by Joshi in the year 1953. The management of this disease can be of two categories: medical...

Comparative Evaluation of Lignocaine 0.5% and Lignocaine 0.5% with Pethidine for Intravenous Regional Anaesthesia in Upper Limb Surgery

Introduction: Intravenous regional anesthesia is particularly useful in the surgery of the extremities, especially in cases with full stomach and as an outpatient technique in orthopedic procedures. The low failure rate,...

Correlation of Serum T3, T4, TSH with Chronic Kidney Disease

Aims and Objectives: Correlation of serum T3, T4, TSH with Chronic kidney disease patients. Material and Methods: The present study was undertaken at Maharana Bhupal Govt. Hospital, attached to R.N.T. Medical College Uda...

An Evaluation of the Metabolic Parameters in Women with Gestational Diabetes Mellitus after Delivery

Objective: To evaluate the metabolic parameters in women with gestational diabetes mellitus after delivery in north Indian women. Methods: This was a comparative study. A total of 50 patients were included in the study....

Download PDF file
  • EP ID EP284411
  • DOI -
  • Views 34
  • Downloads 0

How To Cite

Najmi Arshad Manzoor (2017). Unplanned Interruption of Radiotherapy in Head and Neck Cancers: report from a Regional Cancer Centre. Journal of Medical Science And clinical Research, 5(4), 20294-20300. https://europub.co.uk/articles/-A-284411